Tarsus Pharmaceuticals Inc (TARS)
Stock-Based Compensation
$13.29M
Quarterly · Period ending: · USD
TARS Stock-Based Compensation
Latest reported$13.29Mperiod ending
Latest reported$13.29Mperiod ending
TARS Quarterly Stock-Based Comp ($2.25K → $13.29M)
Quarterly stock-based compensation
High-resolution chart · PNG
TARS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,289,000 | |
| 11,967,000 | |
| 14,314,000 | |
| 12,243,000 | |
| 8,233,000 | |
| 6,930,000 | |
| 7,403,000 | |
| 7,415,000 | |
| 7,481,000 | |
| 5,519,000 | |
| 5,482,000 | |
| 5,250,000 | |
| 5,192,000 | |
| 3,906,000 | |
| 3,671,000 | |
| 3,583,000 | |
| 3,532,000 | |
| 2,674,000 | |
| 2,179,000 | |
| 2,119,000 | |
| 2,794,000 | |
| 1,363,000 | |
| 438,000 | |
| 224,000 | |
| 173,000 | |
| 4,000 | |
| 5,000 | |
| 4,000 | |
| 2,250 | |
| 2,250 |